Urologic Oncology, 1873-2496

Journal

More filtering options
  1. 2020
  2. Hospital readmissions after limited vs. extended lymph node dissection during open and robot-assisted radical prostatectomy

    Stavros I. Tyritzis, Ulrica Wilderäng, Αnna Wallerstedt Lantz, Gunnar Steineck, J. Hugosson, Anders Bjartell, J. Stranne, Eva Haglind & Nils Peter Wiklund, 2020, In : Urologic Oncology: Seminars and Original Investigations. 38, 1, p. 5.e1-5.e8

    Research output: Contribution to journalArticle

  3. 2019
  4. Cell-based evidence regarding the role of FSH in prostate cancer

    Nishtman Dizeyi, Dorota Trzybulska, Yahia Al-Jebari, Ilpo Huhtaniemi & Yvonne Lundberg Giwercman, 2019, In : Urologic Oncology: Seminars and Original Investigations. 37, 4, p. 290.e1-290.e8

    Research output: Contribution to journalArticle

  5. 2018
  6. Recommendations for follow-up of muscle-invasive bladder cancer patients: A consensus by the international bladder cancer network

    Tahlita C.M. Zuiverloon, Kim E.M. van Kessel, Trinity J. Bivalacqua, Joost L. Boormans, Thorsten H. Ecke, Petros D. Grivas, Anne E. Kiltie, Fredrik Liedberg, Andrea Necchi, Bas W. van Rhijn, Florian Roghmann, Marta Sanchez-Carbayo, Bernd J. Schmitz-Dräger, Felix Wezel & Ashish M. Kamat, 2018 Sep, In : Urologic Oncology: Seminars and Original Investigations. 36, 9, p. 423-431

    Research output: Contribution to journalArticle

  7. 2017
  8. 2015
  9. Cardiovascular risk with androgen deprivation therapy for prostate cancer: Potential mechanisms.

    Åsa Tivesten, Jehonathan H Pinthus, Noel Clarke, Wilhelmina Duivenvoorden & Jan Nilsson, 2015, In : Urologic Oncology. 33, 11, p. 464-475

    Research output: Contribution to journalReview article

  10. The role of the prostate cancer gene 3 urine test in addition to serum prostate-specific antigen level in prostate cancer screening among breast cancer, early-onset gene mutation carriers

    Ruben G. Cremers, Rosalind A. Eeles, E. K. Bancroft, Janneke Ringelberg-Borsboom, Hans F. Vasen, Christi J. Van Asperen, Jack A. Schalken, Gerald W. Verhaegh, Lambertus A. Kiemeney, N. Aaronson, A. Ardem-Jones, E. K. Bancroft, C. Bangma, E. Castro, D. Dearnaley, D. Eccles, R. A. Eeles, D. G. Evans, J. Eyfjord, A. Falconer & 20 others, C. S. Foster, H. Grönberg, F. C. Hamdy, O. Johansson, V. Khoo, Z. Kote-Jarai, H. Lilja, J. Lubinski, L. Maehle, J. Melia, C. Mikropoulos, G. Mitchell, A. V. Mitra, S. Moss, C. Moynihan, E. C. Page, G. Rennert, M. Suri, P. Wilson & The IMPACT Steering Committee The IMPACT Steering Committee, 2015, In : Urologic Oncology: Seminars and Original Investigations. 33, 5, p. 202.e19-202.e28

    Research output: Contribution to journalArticle

  11. 2014
  12. Assessment of the bone scan index in a randomized placebo-controlled trial of tasquinimod in men with metastatic castration-resistant prostate cancer (mCRPC).

    Andrew J Armstrong, Reza Kaboteh, Michael A Carducci, Jan-Erik Damber, Walter M Stadler, Mats Hansen, Lars Edenbrandt, Göran Forsberg, Orjan Nordle, Roberto Pili & Michael J Morris, 2014, In : Urologic Oncology. 32, 8, p. 1308-1316

    Research output: Contribution to journalArticle

  13. Protein kinase A (PKA) pathway is functionally linked to androgen receptor (AR) in the progression of prostate cancer.

    Martuza Sarwar, Sabina Sandberg, Per-Anders Abrahamsson & Jenny L Persson, 2014, In : Urologic Oncology. 32, 1

    Research output: Contribution to journalArticle

  14. 2012
  15. 2011
  16. Serotonin activates MAP kinase and PI3K/Akt signaling pathways in prostate cancer cell lines.

    Nishtman Dizeyi, Petter Hedlund, Anders Bjartell, Martina Tinzl, Kristin Austild-Taskén & Per-Anders Abrahamsson, 2011, In : Urologic Oncology. 29, p. 436-445

    Research output: Contribution to journalArticle

  17. 2010
  18. Understanding the agreement of histology of familial testicular tumors

    Hao Liu, Jan Sundquist & Kari Hemminki, 2010, In : Urologic Oncology. 28, 5, p. 465-465

    Research output: Contribution to journalLetter

  19. 2009
  20. EAU-a work in progress-what comes next?

    Per-Anders Abrahamsson, 2009, In : Urologic Oncology. 27, 2, p. 125-126

    Research output: Contribution to journalLetter

  21. 2008
  22. Tissue microarray based analysis of prognostic markers in invasive bladder cancer: Much effort to no avail?

    Fredrik Liedberg, Harald Anderson, G Chebil, Mårten Fernö, Sigurdur Gudjonsson, Mattias Höglund, David Lindgren, Lena-Maria Lundberg, Kristina Lövgren & Wiking Månsson, 2008, In : Urologic Oncology. 26, 1, p. 17-24

    Research output: Contribution to journalArticle

  23. 2005
  24. Quality of life in patients with bladder cancer

    EW Gerharz, Åsa Månsson & Wiking Månsson, 2005, In : Urologic Oncology. 23, 3, p. 201-207

    Research output: Contribution to journalArticle

  25. 2003
  26. 2002
  27. Localization and mRNA expression of somatostatin receptor subtypes in human prostatic tissue and prostate cancer cell lines.

    Nishtman Dizeyi, Lutz Konrad, Anders Bjartell, Hao Wu, Virgil Gadaleanu, Jens Ceder, Lone Helboe & Per-Anders Abrahamsson, 2002, In : Urologic Oncology. 7, 3, p. 91-98

    Research output: Contribution to journalArticle